Literature DB >> 26083267

Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration.

Christiane Richter-Landsberg.   

Abstract

Oligodendrocytes are dependent on an intact, dynamic microtubule (MT) network, which participates in the elaboration and stabilization of myelin forming extensions, and is essential for cellular sorting processes. The microtubule-associated protein tau is constituent of oligodendrocytes. During culture maturation it is developmentally regulated and important for MT stability, MT formation and intracellular trafficking. Downregulation of tau impairs process outgrowth and the transport of myelin basic protein (MBP) mRNA to the cell periphery. Cells fail to differentiate into MBP-expressing, sheet-forming oligodendrocytes. Tau-positive inclusions originating in oligodendrocytes and white matter pathology are prominent in frontotemporal dementias, such as Pick's disease, progressive supranuclear palsy and corticobasal degeneration. An impairment or overload of the proteolytic degradation systems, i.e. the ubiquitin proteasomal system and the lysosomal degradation pathway, has been connected to the formation of protein aggregates. Large protein aggregates are excluded from the proteasome and degraded by autophagy, which is a highly selective process and requires receptor proteins for ubiquitinated proteins, including histone deacetylase 6 (HDAC6). HDAC6 is present in oligodendrocytes, and α-tubulin and tau are substrates of HDAC6. In this review our current knowledge of the role of tau and protein aggregate formation in oligodendrocyte cell culture systems is summarized.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26083267     DOI: 10.1515/hsz-2015-0157

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  7 in total

Review 1.  Epigenetic modifications-insight into oligodendrocyte lineage progression, regeneration, and disease.

Authors:  Alexander Gregath; Qing Richard Lu
Journal:  FEBS Lett       Date:  2018-02-22       Impact factor: 4.124

Review 2.  The oligodendrocyte growth cone and its actin cytoskeleton: A fundamental element for progenitor cell migration and CNS myelination.

Authors:  Elizabeth J Thomason; Miguel Escalante; Donna J Osterhout; Babette Fuss
Journal:  Glia       Date:  2019-11-07       Impact factor: 7.452

3.  Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.

Authors:  Mariet Allen; Xue Wang; Jeremy D Burgess; Jens Watzlawik; Daniel J Serie; Curtis S Younkin; Thuy Nguyen; Kimberly G Malphrus; Sarah Lincoln; Minerva M Carrasquillo; Charlotte Ho; Paramita Chakrabarty; Samantha Strickland; Melissa E Murray; Vivek Swarup; Daniel H Geschwind; Nicholas T Seyfried; Eric B Dammer; James J Lah; Allan I Levey; Todd E Golde; Cory Funk; Hongdong Li; Nathan D Price; Ronald C Petersen; Neill R Graff-Radford; Steven G Younkin; Dennis W Dickson; Julia R Crook; Yan W Asmann; Nilüfer Ertekin-Taner
Journal:  Alzheimers Dement       Date:  2017-10-31       Impact factor: 21.566

4.  Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases?

Authors:  Peter Hoch-Kraft; Jacqueline Trotter; Constantin Gonsior
Journal:  Neurochem Res       Date:  2019-03-06       Impact factor: 3.996

Review 5.  Chromatin remodeling and epigenetic regulation of oligodendrocyte myelination and myelin repair.

Authors:  Elijah Koreman; Xiaowei Sun; Q Richard Lu
Journal:  Mol Cell Neurosci       Date:  2017-12-15       Impact factor: 4.314

6.  Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies.

Authors:  Isidro Ferrer; Meritxell Aguiló García; Margarita Carmona; Pol Andrés-Benito; Benjamin Torrejón-Escribano; Paula Garcia-Esparcia; José Antonio Del Rio
Journal:  Front Aging Neurosci       Date:  2019-05-28       Impact factor: 5.750

Review 7.  Glial Tau Pathology in Tauopathies: Functional Consequences.

Authors:  Martha A Kahlson; Kenneth J Colodner
Journal:  J Exp Neurosci       Date:  2016-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.